Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Joseph Mattingly

Showing results (41-50 of 127) with videos related to

Pageof 13
Sort By:
The American Journal of Emergency Medicine|April 6, 2024
Comments on "GLP-1 agonists: A review for emergency clinicians"T Joseph Mattingly, Grace LaFleur, James H Ruble
Pharmacoeconomics - Open|October 14, 2024
Costs of Illness for Huntington's Disease: A Systematic ReviewDivya Patil, Emily F Gorman, T Joseph Mattingly
Health Affairs Scholar|March 25, 2026
Scope and characteristics of patients filling medications through specialty pharmacies by ownership typeKelly E Anderson, Matthew McEnany, T Joseph Mattingly
Journal of Clinical Pharmacy and Therapeutics|April 8, 2021
Understanding authorized generics-A review of the published clinical dataJustine Alderfer, Richard A Hansen, T Joseph Mattingly
JAMA Health Forum|August 1, 2025
Community Pharmacy Turnover and Context of Openings and Closings by Ownership TypeT Joseph Mattingly, Maitreyi Sahu, Kelly E Anderson
Pharmacoeconomics|August 10, 2016
Publication of Cost-of-Illness Studies: Does Methodological Complexity Matter?T Joseph Mattingly, C Daniel Mullins, Eberechukwu Onukwugha
Journal of Managed Care & Specialty Pharmacy|January 28, 2025
Emerging trends in managed care pharmacy: A mixed-method studyT Joseph Mattingly, Laura E Happe, Laura Cranston
JAMA Health Forum|November 3, 2023
Pharmacy Benefit Managers: History, Business Practices, Economics, and PolicyT Joseph Mattingly, David A Hyman, Ge Bai
Plos One|January 8, 2019
Penicillin skin testing in methicillin-sensitive staphylococcus aureus bacteremia: A cost-effectiveness analysisT Joseph Mattingly, Stephen Meninger, Emily L Heil
Infectious Diseases and Therapy|March 3, 2019
Burden of Co-Infection: A Cost Analysis of Human Immunodeficiency Virus in a Commercially Insured Hepatitis C Virus PopulationT Joseph Mattingly, Neha S Pandit, Eberechukwu Onukwugha
Pageof 13

Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
The American Journal of Emergency Medicine|April 6, 2024
Comments on "GLP-1 agonists: A review for emergency clinicians"T Joseph Mattingly, Grace LaFleur, James H Ruble
Pharmacoeconomics - Open|October 14, 2024
Costs of Illness for Huntington's Disease: A Systematic ReviewDivya Patil, Emily F Gorman, T Joseph Mattingly
Health Affairs Scholar|March 25, 2026
Scope and characteristics of patients filling medications through specialty pharmacies by ownership typeKelly E Anderson, Matthew McEnany, T Joseph Mattingly
Journal of Clinical Pharmacy and Therapeutics|April 8, 2021
Understanding authorized generics-A review of the published clinical dataJustine Alderfer, Richard A Hansen, T Joseph Mattingly
JAMA Health Forum|August 1, 2025
Community Pharmacy Turnover and Context of Openings and Closings by Ownership TypeT Joseph Mattingly, Maitreyi Sahu, Kelly E Anderson
Pharmacoeconomics|August 10, 2016
Publication of Cost-of-Illness Studies: Does Methodological Complexity Matter?T Joseph Mattingly, C Daniel Mullins, Eberechukwu Onukwugha
Journal of Managed Care & Specialty Pharmacy|January 28, 2025
Emerging trends in managed care pharmacy: A mixed-method studyT Joseph Mattingly, Laura E Happe, Laura Cranston
JAMA Health Forum|November 3, 2023
Pharmacy Benefit Managers: History, Business Practices, Economics, and PolicyT Joseph Mattingly, David A Hyman, Ge Bai
Plos One|January 8, 2019
Penicillin skin testing in methicillin-sensitive staphylococcus aureus bacteremia: A cost-effectiveness analysisT Joseph Mattingly, Stephen Meninger, Emily L Heil
Infectious Diseases and Therapy|March 3, 2019
Burden of Co-Infection: A Cost Analysis of Human Immunodeficiency Virus in a Commercially Insured Hepatitis C Virus PopulationT Joseph Mattingly, Neha S Pandit, Eberechukwu Onukwugha
Pageof 13